VIEMED HEALTHCARE, INC. Increase (Decrease) in Accounts Receivable
VIEMED HEALTHCARE, INC. (VMD) reported Increase (Decrease) in Accounts Receivable of $6.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $1.05M.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $5.59M, a 197.82% increase year-over-year.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.83M.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$968.00K.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$1.16M, a 119.07% decline from fiscal 2024.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for fiscal 2024 was $6.07M, a 474.01% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for fiscal 2023 was $1.06M, a 58.61% decline from fiscal 2022.
- VIEMED HEALTHCARE, INC. increase (decrease) in accounts receivable for fiscal 2022 was $2.56M, a 65.20% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $6.64M 10-Q · filed 2026-08-03 | $4.82M derived: sum of 3 quarters · filed 2026-08-03 | $3.85M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $5.59M 10-Q · filed 2026-05-05 | $3.77M derived: sum of 2 quarters · filed 2026-05-05 | $2.80M derived: sum of 3 quarters · filed 2026-05-05 | $2.56M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$2.80M derived: sum of 2 quarters · filed 2026-03-04 | -$3.04M derived: sum of 3 quarters · filed 2026-08-03 | -$1.16M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.21M derived: sum of 2 quarters · filed 2026-08-03 | $670.00K 10-Q · filed 2025-11-05 | -$1.47M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.64M 10-Q · filed 2026-08-03 | -$502.00K derived: sum of 3 quarters · filed 2026-08-03 | -$514.00K derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $1.88M 10-Q · filed 2026-05-05 | -$262.00K derived: sum of 2 quarters · filed 2026-05-05 | -$274.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.93M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$2.15M derived: sum of 2 quarters · filed 2026-03-04 | $47.00K derived: sum of 3 quarters · filed 2026-03-04 | $6.07M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.19M derived: sum of 2 quarters · filed 2025-11-05 | $8.21M 10-Q · filed 2025-11-05 | $8.74M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $8.22M 10-Q · filed 2025-08-06 | $8.75M derived: sum of 3 quarters · filed 2026-03-04 | $8.78M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-03-31 | $6.03M 10-Q · filed 2025-05-07 | $6.55M derived: sum of 2 quarters · filed 2026-03-04 | $6.58M derived: sum of 3 quarters · filed 2026-03-04 | $6.14M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2023-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $558.00K derived: sum of 2 quarters · filed 2026-03-04 | $117.00K derived: sum of 3 quarters · filed 2026-03-04 | $1.06M 10-K · filed 2026-03-04 | ||||
| 2023-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$408.00K derived: sum of 2 quarters · filed 2024-11-06 | $533.00K 10-Q · filed 2024-11-06 | $930.00K derived: sum of 4 quarters · filed 2025-03-10 | ||||
| 2023-06-30 | -$441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $500.00K 10-Q · filed 2024-08-07 | $897.00K derived: sum of 3 quarters · filed 2025-03-10 | $1.59M derived: sum of 4 quarters · filed 2025-03-10 | ||||
| 2023-03-31 | $941.00K 10-Q · filed 2024-05-06 | $5.07M 10-Q · filed 2023-05-08 | $1.34M derived: sum of 2 quarters · filed 2025-03-10 | $2.03M derived: sum of 3 quarters · filed 2025-03-10 | -$724.00K derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $1.09M derived: sum of 2 quarters · filed 2025-03-10 | -$1.67M derived: sum of 3 quarters · filed 2025-03-10 | $2.56M 10-K · filed 2025-03-10 | $12.57M 10-K · filed 2023-03-02 | |||
| 2022-09-30 | $695.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$2.06M derived: sum of 2 quarters · filed 2023-11-01 | $2.16M 10-Q · filed 2023-11-01 | $9.97M 10-Q · filed 2022-11-01 | $3.93M derived: sum of 4 quarters · filed 2023-11-01 | |||
| 2022-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.46M 10-Q · filed 2023-08-09 | $7.76M 10-Q · filed 2022-08-02 | $3.24M derived: sum of 3 quarters · filed 2023-08-09 | $5.65M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $4.22M 10-Q · filed 2023-05-08 | $5.99M derived: sum of 2 quarters · filed 2023-05-08 | $8.40M derived: sum of 3 quarters · filed 2023-05-08 | $8.84M derived: sum of 4 quarters · filed 2023-05-08 | ||||
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $4.18M derived: sum of 2 quarters · filed 2023-03-02 | $4.62M derived: sum of 3 quarters · filed 2023-03-02 | $7.34M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.85M derived: sum of 2 quarters · filed 2022-11-01 | $5.57M 10-Q · filed 2022-11-01 | $8.54M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $3.16M 10-Q · filed 2022-08-02 | $6.13M derived: sum of 3 quarters · filed 2022-08-02 | $8.04M derived: sum of 4 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $2.73M 10-Q · filed 2022-05-03 | $5.70M derived: sum of 2 quarters · filed 2022-05-03 | $7.61M derived: sum of 3 quarters · filed 2022-05-03 | $5.93M derived: sum of 4 quarters · filed 2022-05-03 | ||||
| 2020-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $4.88M derived: sum of 2 quarters · filed 2022-03-07 | $3.20M derived: sum of 3 quarters · filed 2022-03-07 | $9.96M 10-K · filed 2022-03-07 | ||||
| 2020-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $231.00K derived: sum of 2 quarters · filed 2021-11-02 | $6.99M 10-Q · filed 2021-11-02 | $9.66M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $5.07M 10-Q · filed 2021-08-03 | $7.75M derived: sum of 3 quarters · filed 2021-08-03 | $9.76M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $6.75M 10-Q · filed 2021-05-03 | $9.43M derived: sum of 2 quarters · filed 2021-05-03 | $11.44M derived: sum of 3 quarters · filed 2021-05-03 | $14.31M derived: sum of 4 quarters · filed 2021-05-03 | ||||
| 2019-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $4.69M derived: sum of 2 quarters · filed 2021-03-03 | $7.55M derived: sum of 3 quarters · filed 2021-03-03 | $12.51M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $4.88M derived: sum of 2 quarters · filed 2020-11-04 | $9.83M 10-Q · filed 2020-11-04 | $12.08M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $7.82M 10-Q · filed 2020-08-04 | $10.07M derived: sum of 3 quarters · filed 2020-08-04 | $12.31M derived: sum of 4 quarters · filed 2020-08-04 | ||||
| 2019-03-31 | $4.95M 10-Q · filed 2020-05-05 | $7.20M derived: sum of 2 quarters · filed 2020-05-05 | $9.44M derived: sum of 3 quarters · filed 2020-05-05 | |||||
| 2018-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $4.49M derived: sum of 2 quarters · filed 2020-03-04 | $5.25M 10-K · filed 2020-03-04 | |||||
| 2018-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $3.00M 10-Q · filed 2019-11-05 | ||||||
| 2018-06-30 | $761.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |